Enhanced FIB-SEM systems for large-volume 3D imaging

  1. C Shan Xu  Is a corresponding author
  2. Kenneth J Hayworth
  3. Zhiyuan Lu
  4. Patricia Grob
  5. Ahmed M Hassan
  6. José G García-Cerdán
  7. Krishna K Niyogi
  8. Eva Nogales
  9. Richard J Weinberg
  10. Harald F Hess
  1. Janelia Research Campus, Howard Hughes Medical Institute, United States
  2. Howard Hughes Medical Institute, University of California, Berkeley, United States
  3. Howard Hughes Medical Institute, University of California, Berekely, United States
  4. University of North Carolina, United States

Abstract

Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) can automatically generate 3D images with superior z-axis resolution, yielding data that needs minimal image registration and related post-processing. Obstacles blocking wider adoption of FIB-SEM include slow imaging speed and lack of long-term system stability, which caps the maximum possible acquisition volume. Here we present techniques that accelerate image acquisition while greatly improving FIB-SEM reliability, allowing the system to operate for months and generating continuously imaged volumes > 106 µm3. These volumes are large enough for connectomics, where the excellent z resolution can help in tracing of small neuronal processes and accelerate the tedious and time-consuming human proofreading effort. Even higher resolution can be achieved on smaller volumes. We present example data sets from mammalian neural tissue, Drosophila brain, and Chlamydomonas reinhardtii to illustrate the power of this novel high-resolution technique to address questions in both connectomics and cell biology.

Article and author information

Author details

  1. C Shan Xu

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    For correspondence
    xuc@janelia.hhmi.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8564-7836
  2. Kenneth J Hayworth

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Zhiyuan Lu

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Patricia Grob

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ahmed M Hassan

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. José G García-Cerdán

    Department of Plant and Microbial Biology, Howard Hughes Medical Institute, University of California, Berekely, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Krishna K Niyogi

    Department of Plant and Microbial Biology, Howard Hughes Medical Institute, University of California, Berekely, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Eva Nogales

    Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9816-3681
  9. Richard J Weinberg

    Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Harald F Hess

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    The authors declare that no competing interests exist.

Funding

Howard Hughes Medical Institute

  • C Shan Xu
  • Kenneth J Hayworth
  • Zhiyuan Lu
  • Krishna K Niyogi
  • Eva Nogales
  • Harald F Hess

U.S. Department of Energy, Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division (SISGRKN)

  • Krishna K Niyogi
  • Eva Nogales

Gordon and Betty Moore Foundation (GBMF3070)

  • Krishna K Niyogi

NIH (R01 NS-039444)

  • Richard J Weinberg

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeremy Nathans, Johns Hopkins University School of Medicine, United States

Ethics

Animal experimentation: All of the vertebrate animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-258.0) of UNC. UNC's PHS Assurance number is D16-00256 (A3410-01); the AALAC Unit number is 000329.

Version history

  1. Received: February 10, 2017
  2. Accepted: May 9, 2017
  3. Accepted Manuscript published: May 13, 2017 (version 1)
  4. Accepted Manuscript updated: May 16, 2017 (version 2)
  5. Version of Record published: June 19, 2017 (version 3)

Copyright

© 2017, Xu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 23,763
    views
  • 2,422
    downloads
  • 271
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. C Shan Xu
  2. Kenneth J Hayworth
  3. Zhiyuan Lu
  4. Patricia Grob
  5. Ahmed M Hassan
  6. José G García-Cerdán
  7. Krishna K Niyogi
  8. Eva Nogales
  9. Richard J Weinberg
  10. Harald F Hess
(2017)
Enhanced FIB-SEM systems for large-volume 3D imaging
eLife 6:e25916.
https://doi.org/10.7554/eLife.25916

Share this article

https://doi.org/10.7554/eLife.25916

Further reading

    1. Cancer Biology
    2. Cell Biology
    Timothy J Walker, Eduardo Reyes-Alvarez ... Lois M Mulligan
    Research Article

    Internalization from the cell membrane and endosomal trafficking of receptor tyrosine kinases (RTKs) are important regulators of signaling in normal cells that can frequently be disrupted in cancer. The adrenal tumor pheochromocytoma (PCC) can be caused by activating mutations of the rearranged during transfection (RET) receptor tyrosine kinase, or inactivation of TMEM127, a transmembrane tumor suppressor implicated in trafficking of endosomal cargos. However, the role of aberrant receptor trafficking in PCC is not well understood. Here, we show that loss of TMEM127 causes wildtype RET protein accumulation on the cell surface, where increased receptor density facilitates constitutive ligand-independent activity and downstream signaling, driving cell proliferation. Loss of TMEM127 altered normal cell membrane organization and recruitment and stabilization of membrane protein complexes, impaired assembly, and maturation of clathrin-coated pits, and reduced internalization and degradation of cell surface RET. In addition to RTKs, TMEM127 depletion also promoted surface accumulation of several other transmembrane proteins, suggesting it may cause global defects in surface protein activity and function. Together, our data identify TMEM127 as an important determinant of membrane organization including membrane protein diffusability and protein complex assembly and provide a novel paradigm for oncogenesis in PCC where altered membrane dynamics promotes cell surface accumulation and constitutive activity of growth factor receptors to drive aberrant signaling and promote transformation.

    1. Cancer Biology
    2. Cell Biology
    Julian JA Hoving, Elizabeth Harford-Wright ... Alison C Lloyd
    Research Article Updated

    Collective cell migration is fundamental for the development of organisms and in the adult for tissue regeneration and in pathological conditions such as cancer. Migration as a coherent group requires the maintenance of cell–cell interactions, while contact inhibition of locomotion (CIL), a local repulsive force, can propel the group forward. Here we show that the cell–cell interaction molecule, N-cadherin, regulates both adhesion and repulsion processes during Schwann cell (SC) collective migration, which is required for peripheral nerve regeneration. However, distinct from its role in cell–cell adhesion, the repulsion process is independent of N-cadherin trans-homodimerisation and the associated adherens junction complex. Rather, the extracellular domain of N-cadherin is required to present the repulsive Slit2/Slit3 signal at the cell surface. Inhibiting Slit2/Slit3 signalling inhibits CIL and subsequently collective SC migration, resulting in adherent, nonmigratory cell clusters. Moreover, analysis of ex vivo explants from mice following sciatic nerve injury showed that inhibition of Slit2 decreased SC collective migration and increased clustering of SCs within the nerve bridge. These findings provide insight into how opposing signals can mediate collective cell migration and how CIL pathways are promising targets for inhibiting pathological cell migration.